Stay updated on Faricimab in Diabetic Macular Edema Clinical Trial
Sign up to get notified when there's something new on the Faricimab in Diabetic Macular Edema Clinical Trial page.

Latest updates to the Faricimab in Diabetic Macular Edema Clinical Trial page
- Check5 days agoChange DetectedTwo new publications were added to the Publications list, introducing new author names and article details, and one publication was removed to update the study's bibliographic references for RHINE and YOSEMITE results.SummaryDifference0.0%

- Check12 days agoChange DetectedTaoyuan District, Taiwan, 333 was removed as a study site entry. Taoyuan, Taiwan, 333 was added to the list of study locations.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page now shows Revision: v3.5.3, replacing the previous Revision: v3.5.2. This indicates a new build or patch of the site, without changes to study content described in the data.SummaryDifference0.0%

- Check26 days agoChange DetectedThe page footer was updated from revision v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check33 days agoChange DetectedAdded a new publication citation under Publications: Li X et al., Efficacy, Durability, and Safety of Faricimab for Diabetic Macular Edema: 1-Year Results from the China RHINE Subpopulation. Ophthalmol Ther. 2026 Apr 10. Online ahead of print.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded publication: Sheth et al. Four-Year Outcomes of Faricimab in Diabetic Macular Edema (RHONE-X Extension Trial) to the Publications section and updated the page revision to v3.5.0. This update replaces the prior reference to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Faricimab in Diabetic Macular Edema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Faricimab in Diabetic Macular Edema Clinical Trial page.